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OBJECTIVE: To develop two comorbidity indexes con-
structed from the Minimum Dataset (MDS) disease infor-
mation predictive of 18-month mortality and 2 hospi-
talizations in a prevalence cohort of 1424 white, female
nursing-home residents that could be used as part of a
risk adjustment method for quality-of-care outcomes.
METHODS: A split-sample approach was taken for de-
velopment and cross validation of the indexes. Multivari-
ate logistic regression techniques were employed to iden-
tify the MDS diseases most likely to predict each outcome
after controlling for age in the development sample.
Weights equal to the parameter estimates were assigned
to each disease retained in the multivariate model to cre-
ate a single comorbidity index variable for each outcome.
Using the validation samples, the predictive validity of
the MDS-based comorbidity indexes was determined and
compared to other measures of comorbidity (Charlson
Index [ChI], Chronic Disease Score [CDS], count of dis-
eases) as well as to Morris’ activities of daily living (ADL)
index for each outcome.
RESULTS: The MDS-based mortality index included
weighted variables for atherosclerotic heart disease (ASHD),
dysrhythmias, congestive heart failure (CHF), respiratory
disease and depression and had a c-statistic of 0.62 in the
development sample, and 0.60 in both validation samples.
Similar c-statistics were found for the comparison of co-
morbidity and functional status measures. The c-statistics
for the MDS-based hospitalization index (with weighted
variables for hemiplegia, glaucoma, peripheral vascular
disease (PVD), CHF, diabetes and hypertension) were 0.66
and 0.59 for the development sample and validation sam-
ple respectively and were similar to those found for the
other measures.
CONCLUSIONS: Presence or absence of diseases mea-
sured at baseline are weakly predictive of subsequent
hospitalization or mortality in this cohort. Additional pa-
tient risk factors such as disease severity, or change in
functional status should be investigated in future research
aimed at defining risk adjustment methods in this popu-
lation.
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OBJECTIVE: Health-related quality of life (HRQOLs)
are important health-status indicators. The longitudinal
aspect of transitions in HRQOL is not well known. This
study examines how HRQOL changes over time using a
Markov probability model.
METHOD: We analyzed 10,492 elderly persons aged 65
years or older and followed from 1991 to 1994 in MCBS,
a nationally representative sample of the US elderly pop-
ulation. We measured HRQOL by global health percep-
tion, Katz Index of Activities of Daily Living (ADL), and
Instrumental Activities of Daily Living (IADL). We esti-
mated the probability of transition from one state of
HRQOL to another using a Markov probability model.
We investigated the transition matrix of HRQOL by in-
corporating the competing risk of death and socio-demo-
graphic variables including age, race, gender and the in-
teraction terms among them.
RESULTS: Including death as a worst outcome, 1411
persons (13%) had a steady deterioration in global health
perception in the four-year time period. One thousand
one hundred six (1106) (11%) had steady improvement
of health perception, 1047 (10%) had a constant state,
and 6928 (66%) experienced fluctuations in health per-
ception. Similar patterns were found in ADL and IADL
measures. The transition probabilities for a female with a
base age of 70 indicated that one had 34% to 44%
chance of remaining in the same state of general health,
while the probability steadily decreases as the health per-
ception decreases. A male aged 70 years has a probability
of 32% to 53% to remain at the same state. As HRQOL
decreases by one unit, the probability of death increases
steadily from less than 1% to 12% for a female and from
5% to 21% for a male across all HRQOL measures.
CONCLUSION: The study shows the patterns in transi-
tion of HRQOL in the elderly population. The probabili-
ties of transition in three measures of HRQOL are gener-
ally consistent and interpretable.
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OBJECTIVES: This analysis presents trends in the
health-related quality of life of the US population from
1984 to 1994 and examines the hypothesis that fluctua-
tions in population health levels are related to changes in
economic status.
METHODS: Data on health status and quality of life as
well as personal and household characteristics are from
the US National Health Interview Survey and the US Vi-
tal and Health Statistics System. To examine the relation-
ship between health and economic well being, these data
are linked to economic data, including medical care in-
puts.
RESULTS: Health-related quality of life and quality-ad-
justed life years rose from 1984 to 1990 and declined af-
ter this period. Specifically, for the total population,
quality-adjusted life years rose from 63.4 in 1984 to 64.5
years in 1990 and declined to 64.0 in 1994. Similar pat-
terns were observed across genders and ethnic subgroups.
The changes in quality of life and mortality coincided
with periods of economic growth and recession over the
same interval. Regression analyses indicate that per cap-
ita income levels and unemployment rates are important
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in explaining variations in population health within a
given year as well as across years within this time period.
Population health levels are further analyzed to examine
whether changes are related to personal and household
characteristics, economic environment, and availability
of medical care inputs.
CONCLUSIONS: These analyses indicate that changes in
health-related quality of life can occur due to factors
other than health-care interventions, a finding which has
important implications for the selection and use of nor-
mative data for interpretation of findings.
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DOES ILLNESS-RELATED LOST PRODUCTIVE 
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Stewart WF, Ricci J, Leotta CR, Chee E
AdvancePCS, Hunt Valley, MD, USA
OBJECTIVE: To determine if lost work time differs by
job demand and control among workers with AR. Work
loss estimates were derived for missed workdays, missed
hours, and reduced productivity on days at work while
not feeling well. METHODS: Three different phone in-
terviews were developed to quantify illness-related work
loss. Two different recall periods, at one week and four
weeks, were used for each interview. A convenience sam-
ple (n  20,088) of adult residents from the Baltimore,
MD and Chicago, IL areas was contacted by phone, of
whom 7,691 met occupation eligibility criteria. The inter-
views included questions on job demand and control, and
health questions to screen for AR symptoms and deter-
mine AR severity.
RESULTS: Mean lost work time per week was calculated
among respondents with jobs categorized as high demand-
high control (HH), high demand-low control (HL), low
demand-high control (LH), and low demand-low control
(LL). Among AR cases (n  1596), job demand-control
was significantly (p  .05) related to the number of missed
workdays per week for health reasons, but not to the mean
total hours of lost productive time per week at work while
not feeling well. AR cases in HL jobs missed significantly
more workdays for health reasons than non-AR controls
(1.3 days versus 0.38 days; p  .0001). This was not ob-
served for AR cases in the other demand-control job cate-
gories, or for mild AR cases in HL jobs. Among moderate-
to-severe AR cases in HL jobs, the mean number of missed
workdays increased to 1.74 days per week.
CONCLUSION: AR symptoms are associated with lost
work time. However, the way in which work time is lost
appears to vary with the level of job demand and control.
Given little latitude to adjust work performance to ac-
commodate AR symptoms, individuals in high demand-
low control jobs may be more likely to miss work.
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OBJECTIVE: To determine the net direct medical cost
and utilization patterns of asthma in a public Medicaid
program.
METHODS: A retrospective matched case-control design
was used. Administrative claims data were obtained for
persons eligible for Medicaid benefits in North Carolina
from May 1996 through April 1998. Asthma cases were
defined as persons who had at least one inpatient claim
for asthma (ICD-9-CM  493.) or had two or more out-
patient asthma claims in the first year. A group of control
subjects matched 1 to 1 on age, gender, and race was ob-
tained. Persons who had a diagnosis for emphysema,
COPD, or cancer or who were not between 1 and 65
years of age were excluded. Net costs were determined
using the second year (May 1997 to April 1998) follow-
ing the recruitment period. Adjusted differences were ob-
tained from a generalized least square model using Huber
White heteroscedasticity consistent variance–covariance
matrix with terms to control for comorbidity burden,
Medicare eligibility, and duration of eligibility.
RESULTS: Thirteen thousand two hundred fifty five
asthma cases were identified with a mean age of 16 years,
50% of who were black, and 56% were female. Asthma
cases had a higher comorbidity burden than controls,
particularly for diabetes, psychoses, hypertension, and
anemia. The average total annual cost was $3226 for
asthma cases compared to $2015 (p  .05) for controls.
This translated to a net un-adjusted annual cost of $1210
or $111 per member per month (PMPM). After multi-
variate adjustment, the net annual cost of asthma was es-
timated at $821 and $77 PMPM. Twice as many cases
had emergency room visits and inpatient hospitalizations
than did controls and prescription expenditures were
over 100% higher than controls.
CONCLUSION: Caring for indigent persons with
asthma costs approximately 50% more than for similar
persons without asthma. Inpatient and prescription ex-
penditures account for approximately 50% of the addi-
tional expense.
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